These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1955735)

  • 1. Transforming growth factor-beta: an important mediator of immunoregulation.
    Kehrl JH
    Int J Cell Cloning; 1991 Sep; 9(5):438-50. PubMed ID: 1955735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
    Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
    J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S; Seelig M; Lee HM; Lin J
    J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness.
    Rook AH; Kehrl JH; Wakefield LM; Roberts AB; Sporn MB; Burlington DB; Lane HC; Fauci AS
    J Immunol; 1986 May; 136(10):3916-20. PubMed ID: 2871107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta and the immune response: implications for anticancer therapy.
    Wrzesinski SH; Wan YY; Flavell RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5262-70. PubMed ID: 17875754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TGF-beta in immune-evasion of cancer.
    Beck C; Schreiber H; Rowley D
    Microsc Res Tech; 2001 Feb; 52(4):387-95. PubMed ID: 11170297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
    Saito S; Morii T; Enomoto M; Sakakura S; Nishikawa K; Narita N; Ichijo M
    Cell Immunol; 1993 Dec; 152(2):605-13. PubMed ID: 7504983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
    Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
    Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of transforming growth factor-beta1 in prostate cancer.
    Wikström P; Damber J; Bergh A
    Microsc Res Tech; 2001 Feb; 52(4):411-9. PubMed ID: 11170300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor type beta 1 (TGF-beta 1) down-regulates interleukin-2 production and up-regulates interleukin-2 receptor expression in a thymoma cell line.
    D'Angeac AD; Dornand J; Emonds-Alt X; Jullien P; Garcia-Sanz JA; Erard F
    J Cell Physiol; 1991 Jun; 147(3):460-9. PubMed ID: 2066366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.
    Wahl SM; Hunt DA; Wong HL; Dougherty S; McCartney-Francis N; Wahl LM; Ellingsworth L; Schmidt JA; Hall G; Roberts AB
    J Immunol; 1988 May; 140(9):3026-32. PubMed ID: 3129508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta 1 enhances the generation of allospecific cytotoxic T lymphocytes.
    Kondo S; Isobe K; Ishiguro N; Nakashima I; Miura T
    Immunology; 1993 Jul; 79(3):459-64. PubMed ID: 8406573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.
    Geissmann F; Revy P; Regnault A; Lepelletier Y; Dy M; Brousse N; Amigorena S; Hermine O; Durandy A
    J Immunol; 1999 Apr; 162(8):4567-75. PubMed ID: 10201996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.
    Snapper CM; Waegell W; Beernink H; Dasch JR
    J Immunol; 1993 Nov; 151(9):4625-36. PubMed ID: 8409423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.
    Valenti R; Huber V; Filipazzi P; Pilla L; Sovena G; Villa A; Corbelli A; Fais S; Parmiani G; Rivoltini L
    Cancer Res; 2006 Sep; 66(18):9290-8. PubMed ID: 16982774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
    Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
    Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.